ELSA unveils agenda for Dublin Life Settlement Symposium 2026

The European Life Settlement Association has announced speakers and sessions for its Dublin symposium on 15 September 2026, bringing law, investment and technology voices together in Ireland. The agenda centers on Brexit, litigation risk, investor sentiment and artificial intelligence in the life settlement market.

Why it matters: - The Dublin Life Settlement Symposium 2026 will bring legal, investment and life settlement professionals together at a time when Brexit, regulation, investor sentiment and AI are reshaping the market. - The event is designed to give attendees a clearer view of the risks and opportunities facing Europe’s life settlement sector.

What happened: - The European Life Settlement Association announced the agenda and speakers for the Dublin Life Settlement Symposium 2026. - The symposium will take place on 15 September 2026 in Dublin, Ireland. - The program is set to run as an afternoon conference followed by an evening networking reception. - Chris Wells, executive director of the European Life Settlement Association, said the event is intended to bring together leading voices from across the life settlement ecosystem.

The details: - The conference will open with a keynote from Professor Federico Fabbrini, Full Professor of EU Law and Founding Director of the Dublin European Law Institute at Dublin City University, and Fulbright Schuman Fellow in International Security at Harvard Kennedy School. - Fabbrini’s keynote will focus on the continuing implications of Brexit for financial services and international markets. - A panel on Ireland’s role in the global life settlement market will feature David Naughton of Byrne Wallace Shields. - That session will examine Ireland’s legal and regulatory framework, recent developments and opportunities for investors and market participants operating across Europe. - Sherry Duarte of Fifth Season Investments will chair a litigation session featuring Khai LeQuang of Orrick and James Westerlind of ArentFox Schiff. - The litigation panel will address significant litigation, emerging legal risks and recent regulatory developments affecting the life settlement market. - Manu Mazumdar of Conning will present preliminary findings from the Conning/ELSA Investor Sentiment Survey. - The survey presentation will offer an early look at institutional investor attitudes, market confidence and the forces shaping the market’s future direction. - The final panel will focus on Artificial Intelligence — Misuse, Overuse and No Use. - That discussion will feature Matthew Sheridan of the Health Data Analytics Institute and Martin Kramer of Longevity Holdings. - The AI session will examine where the technology can create value, where risks remain and how firms can separate useful innovation from unnecessary complexity. - The event will close with a networking reception for delegates from the international life settlement community. - ELSA said the full agenda and registration details are available here.

Between the lines: - The agenda shows ELSA putting a broad policy-and-market lens on the life settlement business rather than treating the symposium as a narrow industry meetup. - The mix of Brexit, litigation, investor sentiment and AI suggests the sector is dealing with both regulatory uncertainty and operational change. - The inclusion of an investor sentiment survey points to interest in how institutional capital views the market heading into 2026.

What's next: - ELSA will hold the symposium in Dublin on 15 September 2026. - Attendees will hear the survey findings, panel discussions and keynote remarks on the day of the event. - Networking after the conference is expected to extend the day’s discussion across the international life settlement community.